ABVC BioPharma, Inc. Debt Instrument, Convertible, Conversion Price
ABVC BioPharma, Inc. (ECOC) had Debt Instrument, Convertible, Conversion Price of $1.05 per share as of 2023-02-23, per its 10-Q filed 2023-08-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleConversionPrice1 · last filed 2023-08-14
- 2023-02-23: Debt Instrument, Convertible, Conversion Price $1.05.
- 2022-06-30: Debt Instrument, Convertible, Conversion Price $1.00.
- 2021-05-17: Debt Instrument, Convertible, Conversion Price $2.25.
- 2019-08-31: Debt Instrument, Convertible, Conversion Price $7.00.
| Period end | Debt Instrument, Convertible, Conversion Price |
|---|---|
| 2023-02-23 | $1.05 10-Q · filed 2023-08-14 |
| 2022-06-30 | $1.00 10-Q · filed 2022-08-15 |
| 2021-05-17 | $2.25 10-K · filed 2023-03-31 |
| 2019-08-31 | $7.00 10-Q · filed 2022-11-14 |